LPCN icon

Lipocine

28 hedge funds and large institutions have $3.17M invested in Lipocine in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 19 closing their positions.

Holders
28
Holders Change
-12
Holders Change %
-30%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
5
Reduced
8
Closed
19
Calls
$39K
Puts
$49K
Net Calls
-$10K
Net Calls Change
+$635K
Name Market Value Shares Shares
Change
Shares
Change %
AG
26
Advisor Group
Arizona
$2K 68 +68 New
QCMA
27
Quad Capital Management Advisors
New York
$32 1,235 +1,235 New
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
CC
29
Carlson Capital
Texas
-39,412 Closed
VMI
30
VHCP Management II
New York
-22,760 Closed
PM
31
Prosight Management
Texas
-21,947 Closed
RA
32
Royce & Associates
New York
-8,365 Closed
Millennium Management
33
Millennium Management
New York
-7,872 Closed
DAM
34
DLD Asset Management
New York
-7,000 Closed
PPA
35
Parametric Portfolio Associates
Washington
-843 Closed
WVP
36
Worth Venture Partners
New Jersey
-755 Closed
SIM
37
Spark Investment Management
New York
-741 Closed
DS
38
DRW Securities
Illinois
-706 Closed
AAP
39
Ardsley Advisory Partners
Connecticut
-588 Closed
JPMorgan Chase & Co
40
JPMorgan Chase & Co
New York
-533 Closed
CPP
41
Crow Point Partners
Massachusetts
-377 Closed
CA
42
Centerpoint Advisors
Massachusetts
-353 Closed
Citigroup
43
Citigroup
New York
-203 Closed
QCG
44
Quadrant Capital Group
Ohio
-124 Closed
AIM
45
Advantage Investment Management
Iowa
-85 Closed
TRCT
46
Tower Research Capital (TRC)
New York
-63 Closed
FMA
47
FNY Managed Accounts
New York
-29 Closed
CHP
48
Cable Hill Partners
Oregon
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
Citadel Advisors
50
Citadel Advisors
Florida